Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-7 of 7
Keywords: Hexamethylmelamine
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Primary Treatment of Regional and Disseminated Pancreatic Cancer with Hexamethylmelamine, Mitomycin C and 5-Fluorouracil Infusion
Available to PurchaseSubject Area:
Oncology
Howard W. Bruckner, Jill Kalman, Melvin Spigelman, Mayer I. Gorbaty, Nina Butwell, Jody Storch, Anne McKenna
Journal:
Oncology
Oncology (1989) 46 (6): 366–371.
Published Online: 26 June 2009
...Howard W. Bruckner; Jill Kalman; Melvin Spigelman; Mayer I. Gorbaty; Nina Butwell; Jody Storch; Anne McKenna Hexamethylmelamine, mitomycin C and 5-fluorouracil infusion (HexMF) achieved a median survival of 9 months for the 45 patients with either metastatic stage III or unresectable stage II...
Journal Articles
Treatment of Ovarian Cancer with a Combination of Cis-Platinum, Adriamycin, Cyclophosphamide and Hexamethylmelamine
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1982) 39 (4): 205–208.
Published Online: 11 June 2009
...D.V. Razis; E. Poulakou; A. Petounis; G. Papadimitriou; P. Kosmides; G. Delides During the last 2½ years, 38 patients with ovarian cancer were treated with a combination of cis-platinum (CPDD), 50 mg/m 2 , adriamycin, 30 mg/m 2 , cyclophosphamide, 300 mg/m 2 , on day 1; and hexamethylmelamine (HMM...
Journal Articles
Phase II Trial of Combination Chemotherapy for Pancreatic Cancer with 5-Fluorouracil, Mitomycin C, and Hexamethylmelamine
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1983) 40 (3): 165–169.
Published Online: 11 June 2009
...Howard W. Bruckner; Jody A. Storch; John C. Brown; Judith Goldberg; Karen Chamberlin A combination consisting of hexamethylmelamine 150 mg/m 2 D2–15, mitomycin C 10 mg/m 2 D2 and 5-fluorouracil 30 mg/kg/day as a continuous infusion for 5 days, in 4–5 week cycles, underwent phase II trial as primary...
Journal Articles
Phase II Trial of Combination Chemotherapy of Colonic Cancer with 5-Fluorouracil, Mitomycin C, and Hexamethylmelamine
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1983) 40 (3): 161–164.
Published Online: 11 June 2009
...Howard W. Bruckner; Jody A. Storch; John C. Brown; Judith Goldberg; Karen Chamberlin HexMF consists of hexamethylmelamine 150 mg/m 2 D2–15, mitomycin C (MMC) 10 mg/m 2 D2 and 5-fluorouracil (5-FU) 30 mg/kg/day as a continuous infusion Dl-5 in 4–5 week cycles. It was designed as an alternative...
Journal Articles
Combination Chemotherapy with CCNU (NSC-79037), Hexamethylmelamine (NSC-13875) and Methotrexate (NSC-740) in Advanced Bronchogenic Carcinoma
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1975) 32 (2): 82–85.
Published Online: 09 June 2009
...Nicholas J. DiBella; Roald A. Nelson; Michael J. Norgard 18 patients with metastatic or recurrent bronchogenic carcinoma and one patient with a squamous cell carcinoma of the trachea were treated with a combination of CCNU, hexamethylmelamine and methotrexate. Objective remissions were observed...
Journal Articles
A Phase III Study in Lung Carcinoma Comparing Hexamethylmelamine (NSC 13875) to Dibromodulcitol (NSC 104800)
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1975) 31 (5-6): 293–309.
Published Online: 09 June 2009
...W.L. Wilson; J. Van Ryzin; A.J. Weiss; R.W. Frelick; S.E. Moss A phase III study was designed comparing the effectiveness of Hexamethylmelamine (NSC 13875) to Dibromodulcitol (NSC 104800) in lung carcinoma. 250 of the 316 patients entered on the study were stratified into groups according to stage...
Journal Articles
Therapy of Small Cell Carcinoma of the Lung with Hexamethylmelamine
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (1978) 35 (1): 29–32.
Published Online: 09 June 2009
...M.N. Huang; H. Takita; H. Catane; Yee Chen Hexamethylmelamine (HXM) is one of the substituted melamines derived from cyanuric chloride [1]. Previous studies with HXM have shown activity against small cell carcinoma of the lung, when it was given as a single agent [2, 3]. Because of relatively mild...